Zepbound has one list price and at least six real ones, and which one is yours depends on who pays, not on where you shop. A commercial plan that covers it can take it to $25. A plan that refuses it, or no plan at all, lands you on Lilly's self-pay prices of $299 to $449. Medicare now has a $50 route for one form of it. This page sets out each of them with the maker's or the government's own wording, and the without-insurance guide takes the cash side dose by dose.
Zepbound cost by who pays
| Your situation | What you pay a month | Which Zepbound |
|---|---|---|
| Commercial plan that covers it, with Lilly's savings card | as little as $25; card pays up to $100 a month, $1,300 a year1 | single-dose pen |
| Commercial plan that does not cover it, with the card | as low as $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg)3 | KwikPen |
| Same plan, single-dose pen instead | as low as $4993 | single-dose pen |
| No insurance, LillyDirect self-pay | $299, $399, then $449 with refills within 45 days; $499 and $699 otherwise4 | KwikPen or vial |
| Medicare, GLP-1 Bridge (weight) | $50 per 28-day supply810 | KwikPen only |
| Medicare Part D (sleep apnea) | your plan's cost sharing11 | as your plan lists it |
| Medicaid | nominal, where your state covers it1213 | state by state |
| Compounded tirzepatide (not Zepbound) | from $85 on our board | not FDA-approved |
Zepbound cost with insurance that covers it
Lilly's card is for people whose plan covers the single-dose pen. In Lilly's words, you "must have commercial drug insurance that covers Zepbound single-dose pen" to "pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill". The card's savings are capped at "$100 per 1-month prescription, $200 per 2-month prescription, or $300 per 3-month prescription fill" and "$1,300 per calendar year".1 It also stops after 13 fills in a calendar year, and the current terms end the year itself: "Card expires and savings end on 12/31/2026."2 Expect Lilly to publish 2027 terms; until it does, nobody can tell you the card's January price.
So the card does one thing: it takes up to $100 off whatever your plan would have charged you. Whether you land on $25 depends on that starting number:
| What your plan charges you for a 1-month fill | What the card takes off | What you pay |
|---|---|---|
| $40 copay | $15 | $25 |
| $125 copay | $100 | $25 |
| $200 copay | $100 (the cap) | $100 |
| $400 (deductible month or coinsurance) | $100 (the cap) | $300 |
Any copay up to $125 ends at $25. Above that, you pay your plan's charge minus $100. The yearly cap lines up with the monthly one: $100 a fill across 13 four-week fills is exactly $1,300, so on monthly fills the two run out together at the end of the year. The rows above are worked examples, not quotes from any plan: your plan's own number is on your benefits summary or in your insurer's app.
Two places this goes wrong. A high-deductible plan bills the drug at the plan's rate until the deductible is met, and that rate is set against a list price of about $1,086 a month,7 so the first months of a plan year can cost several hundred dollars even with the card. And a coinsurance plan charges a percentage of that rate every month. The cost with insurance guide works through deductibles, coinsurance and copay accumulators across all four brand drugs.
Does your plan cover Zepbound?
Coverage of Zepbound for weight is set by your employer or plan, not by the insurer's brand. The clearest recent change: CVS Caremark said it "will add Zepbound back to our commercial formularies as an additional preferred option October 1, 2026", and in the same document that "Plan sponsors that adopt CVS Caremark template formularies retain discretion to customize coverage for their members."14 So a Caremark card in your wallet means it may be covered, not that it is.
We keep a sheet per insurer that quotes its own published policy on Zepbound, with the date we read it: Aetna, Anthem, Blue Cross Blue Shield, Cigna, UnitedHealthcare, Humana, Kaiser Permanente, TRICARE and the rest on the coverage tracker. Most plans that cover it require prior authorization; the Zepbound prior authorization letter lays out what reviewers check, for your prescriber to complete, and the appeal guide covers a refusal.
Zepbound cost when your plan does not cover it
This is the most common answer for weight loss, and Lilly has a card for it. With "commercial drug insurance that does not cover Zepbound", the KwikPen fills at "as low as $299" for 2.5 mg, "$399" for 5 mg and "$449" for 7.5, 10, 12.5 and 15 mg, and the single-dose pen at "as low as $499".3 The KwikPen holds a month of four weekly doses in one pen, which is why it is priced like the self-pay products rather than like the insured pen.
The KwikPen version of the card has one condition worth reading twice: it requires "a commercial drug insurance plan that does not provide coverage for Zepbound single-patient-use KwikPen".5 If your plan does cover the KwikPen, your plan's own copay applies instead. And a self-pay purchase sits outside your plan: Lilly's self-pay KwikPen card has you agree "not to apply those out-of-pocket costs toward your deductible or true out-of-pocket obligations",19 so if you expect to meet your deductible this year, ask your plan which route costs less over the year.
Zepbound cost without insurance
Uninsured, you pay Lilly's self-pay price: $299 at 2.5 mg, $399 at 5 mg, and $449 from 7.5 mg as long as you "complete your refill purchase ... within 45 days" of the previous one. Miss the window and the regular price applies: "$499 for 7.5 mg, $699 for 10 mg, $699 for 12.5 mg, and $699 for 15 mg".4 The vial and the KwikPen cost the same at each strength.
What that adds up to over a year, at each dose you might settle on, is worked out in the Zepbound without insurance guide, and the KwikPen guide covers the pen itself and the needles it needs.
Zepbound on Medicare
Medicare "has been prohibited by law from covering medications when used specifically for weight loss",11 and that has not changed inside Part D. What changed is a separate federal program. From July 1, 2026, Medicare.gov lists Zepbound under the Medicare GLP-1 Bridge as "KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens."8 The cost is "a $50 copayment to the pharmacy for a one-month supply", and because a separate program pays, the copay "Doesn’t count towards your yearly Medicare drug plan deductible".9 Lilly's page adds that a refill needs no new approval "even when your dose goes up", and that you "will also need separate pen needles".10
- Who qualifies: 18 or older with a BMI of 35 or higher, or 30 or higher with at least one listed condition, and a prior authorization from your prescriber, valid "through December 31, 2027, unless you change GLP-1s".9
- Sleep apnea: Part D plans can cover GLP-1s for "sleep apnea", and people already covered that way "will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge".11 Your plan's normal cost sharing applies there, not the $50.
- The savings card: not for you. Lilly's terms exclude anyone enrolled in "Medicaid, Medicare, Medicare Part D, Medicare Advantage" and other government programs.5
The Medicare guide covers the Bridge in full, and the Medicare Bridge checker walks through the eligibility questions.
Zepbound on Medicaid
Medicaid is the one payer where the answer is mostly your state. Federal rules make obesity coverage optional, but coverage is required for "moderate to severe obstructive sleep apnea in adults with obesity (Zepbound)"; for weight loss, KFF counted "13 state Medicaid programs covering GLP-1s for obesity treatment under FFS as of January 2026".12 CMS's BALANCE model, which states can join, includes "the KwikPen formulation of Zepbound", and it "will not affect out-of-pocket costs for Medicaid enrollees, which are limited to nominal amounts under federal law."13 Our state-by-state coverage table lists each state's Medicaid position, and the Medicaid guide explains how to check yours.
Zepbound at Walmart, CVS, Walgreens and other pharmacies
People search for the Zepbound price at a named chain, and the honest answer is that the chain matters less than the program. Since March 2026 Lilly has sold the KwikPen at self-pay prices "at LillyDirect ® and major pharmacies nationwide, starting at $299 per month for the 2.5 mg dose", through a self-pay savings card that gives "the same self‑pay prices offered through LillyDirect". The card "applies only to the Zepbound KwikPen and does not apply to single-dose vials or the single-dose pen."6
- Walmart: the first in-store pickup pharmacy for LillyDirect's self-pay vials, so a vial ordered through LillyDirect can be collected at a Walmart pharmacy without using insurance.15
- CVS: said that "By early fourth quarter of 2026" Zepbound patients would see cash-pay pricing in the CVS Health app for pickup in its pharmacies.16
- Any pharmacy: with the KwikPen self-pay card, the price is Lilly's self-pay price.6 Without a card or coverage, the pharmacy charges its own cash price, which Lilly does not publish and we have not verified, so we do not quote one.
The Costco and pharmacy chains guide covers what each chain offers across GLP-1s, and the GoodRx guide explains what discount cards do and do not do for brand-name GLP-1s.
Zepbound on TrumpRx
TrumpRx.gov lists both the vial and the KwikPen, but it does not sell them. For the vial it says "Eli Lilly and Company manages all Zepbound (Tirzepatide) Vial orders through LillyDirect®",18 and for the KwikPen that "LillyDirect® will guide you to savings options, eligibility confirmation, and offers delivery options or transfer to a retail pharmacy of your choosing."17 It also tells insured visitors to "check your co-pay first".17 Going through TrumpRx leads to the same LillyDirect prices above; the TrumpRx guide lists every GLP-1 on the site.
Zepbound through a telehealth program
If you have no prescriber yet, a telehealth program can handle the visit and the prescription. These are the programs we track that list branded Zepbound, priced from each program's own page, cheapest first:
Read the plan details on each one: some charge a membership on top of the medication, and the all-in figure on the board includes any fee we have verified.
The cheaper molecule: compounded tirzepatide
Zepbound's active ingredient, tirzepatide, is also compounded by licensed pharmacies and sold through telehealth programs. It is not FDA-approved: the finished product has not been through FDA review for safety, effectiveness or manufacturing quality. It is priced from $85 a month, against Lilly's $299 to $449. Every seller we track, priced from its own page:
Before you pick a seller on price, check it in ten minutes, and see the compounded tirzepatide page for how the product differs.
Which Zepbound price is yours
- Your plan covers the single-dose pen: $25 a month on a copay of $125 or less, your copay minus $100 above that, with the card.
- Your plan does not cover it: the KwikPen with Lilly's card, $299 to $449 a month, at LillyDirect or a retail pharmacy.
- No insurance: the same $299 to $449 self-pay, kept only with refills inside 45 days.
- Medicare, for weight: $50 a month for the KwikPen through the Bridge, if you qualify.
- Medicaid: ask your state; obesity coverage is optional and sleep apnea coverage is required.
- Price comes first: compounded tirzepatide from $85 a month, without FDA approval.
